Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation

• Main Authors: Xiaoye Li (Author), Xiaochun Zhang (Author), Qinchun Jin (Author), Ying Xue (Author), Wenjing Lu (Author), Junbo Ge (Author), Daxin Zhou (Author), Qianzhou Lv (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objective: Due to the clinical complexity of warfarin, novel oral anticoagulation (NOAC) has been a feasible and safe alternative anticoagulant approach during left atrial appendage closure (LAAC). This study was designed to compare the efficacy and safety of rivaroxaban and dabigatran for nonvalvul...